Clinical Trials Logo

Clinical Trial Summary

This study will assess the role for an oral targeted medication, abrocitinib, as a new treatment option for food allergy patients that would avoid injections. Abrocitinib, which has successfully completed phase three trials for atopic dermatitis, could serve as a single therapy for two conditions in many patients with multiple atopic conditions.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05069831
Study type Interventional
Source Icahn School of Medicine at Mount Sinai
Contact Yair Bitton, MBA, MPH
Phone 347-466-2547
Email [email protected]
Status Not yet recruiting
Phase Phase 1
Start date November 2021
Completion date January 2023

See also
  Status Clinical Trial Phase
Withdrawn NCT03089476 - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy N/A
Completed NCT02552537 - iFAAM: The Impact of Proton-pump Inhibitors (Antacids) on Threshold Dose Distributions Phase 4
Completed NCT01634737 - Crustacean Allergy and Dust Mites Sensitization N/A
Recruiting NCT05072665 - Fast Allergy Sensitivity Test N/A
Active, not recruiting NCT04887441 - Allergology: Information, Data and Knowledge Organization
Recruiting NCT03265262 - The Basophil Activation Test as a Diagnostic Tool in Pediatric Food Allergy N/A
Active, not recruiting NCT04186949 - Early Origins of Allergy and Asthma
Completed NCT02490007 - Pertussis Immunisation and Food Allergy
Recruiting NCT03151252 - Improvement of Foodallergy Diagnostic in Gastrointestinal Tract N/A
Completed NCT02159833 - Intranasal Diagnostics in Food Allergy: a Feasibility Study N/A
Completed NCT02377284 - Prevention and Management of Food Allergies N/A
Completed NCT02354729 - Encouraging Allergic Young Adults to Carry Epinephrine N/A
Completed NCT02640560 - One-year Survey of Anaphylaxis in Outpatient Children Allergic to Peanuts, Walnuts/Hazelnuts, Shellfish N/A
Recruiting NCT04606615 - Skin Barrier Abnormalities and Oxidative Stress Response
Recruiting NCT05038904 - Preventing Anaphylaxis With Acalabrutinib Phase 2
Completed NCT02295397 - Integrated Approaches to Food Allergen and Allergy Risk Management N/A
Terminated NCT02341040 - Evaluation of Potential Allergenicity of New Wheat Varieties
Completed NCT02223182 - Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Phase 1/Phase 2
Completed NCT03349047 - Anxiety About Casual Exposure to Food Allergens N/A
Not yet recruiting NCT04761835 - STEP-IT-UP - Peanut Allergy Study for Infants Phase 2